Peng Luo
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 23
- Oncology 127
- Cancer Immunotherapy and Biomarkers 69
- Lung Cancer Research Studies 22
- Co-authors
- Jian Zhang (137 shared papers)Anqi Lin (100 shared papers)Quan Cheng (98 shared papers)Zaoqu Liu (68 shared papers)Hao Zhang (39 shared papers)Ting Wei (20 shared papers)Zaoqu Liu (22 shared papers)Nan Zhang (27 shared papers)
- Journals
- Frontiers in Immunology (22 papers)Molecular Cancer (10 papers)Frontiers in Pharmacology (7 papers)Frontiers in Cell and Developmental Biology (6 papers)Journal of Translational Medicine (6 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Peng Luo
347 papers receiving 6.0k citations
Peng Luo's Hit Papers
Peers
Comparison fields: 5 of 175
- Cancer Research 1.2k
- Oncology 2.0k
- Immunology 1.3k
- Pulmonary and Respiratory Medicine 1.4k
- Health Informatics 49
Countries citing papers authored by Peng Luo
This map shows the geographic impact of Peng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Luo more than expected).
Fields of papers citing papers by Peng Luo
This network shows the impact of papers produced by Peng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Luo. The network helps show where Peng Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Peng Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 389 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunosenescence: molecular mechanisms and diseases Hit paper breakdown → | 2023 | 421 |
| 2 | Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer Hit paper breakdown → | 2020 | 246 |
| 3 | Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials Hit paper breakdown → | 2023 | 228 |
| 4 | Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts Hit paper breakdown → | 2022 | 174 |
| 5 | 2019 | 165 | |
| 6 | 2015 | 129 | |
| 7 | Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database Hit paper breakdown → | 2023 | 114 |
| 8 | 2019 | 91 | |
| 9 | 2023 | 90 | |
| 10 | 2021 | 89 | |
| 11 | 2022 | 89 | |
| 12 | 2022 | 88 | |
| 13 | 2023 | 79 | |
| 14 | 2017 | 78 | |
| 15 | 2020 | 67 | |
| 16 | 2022 | 66 | |
| 17 | 2023 | 65 | |
| 18 | CTLs heterogeneity and plasticity: implications for cancer immunotherapy Hit paper breakdown → | 2024 | 62 |
| 19 | 2012 | 58 | |
| 20 | iMLGAM: Integrated Machine Learning and Genetic Algorithm‐driven Multiomics analysis for pan‐cancer immunotherapy response prediction Hit paper breakdown → | 2025 | 57 |
About Peng Luo
Peng Luo is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 389 papers that have together received 6.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (69 papers), Ferroptosis and cancer prognosis (63 papers), Cancer-related molecular mechanisms research (26 papers), Immune Cell Function and Interaction (26 papers), Lung Cancer Treatments and Mutations (26 papers), Immune cells in cancer (24 papers), RNA modifications and cancer (23 papers) and Lung Cancer Research Studies (22 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (2.0k citations), Immunology (1.3k citations), Pulmonary and Respiratory Medicine (1.4k citations) and Health Informatics (49 citations). Peng Luo has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jian Zhang, Anqi Lin, Quan Cheng, Zaoqu Liu, Hao Zhang, Ting Wei, Zaoqu Liu, Nan Zhang, Xinwei Han and Yuqing Ren. Their work appears in journals such as Frontiers in Immunology, Molecular Cancer, Frontiers in Pharmacology, Frontiers in Cell and Developmental Biology and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.